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chondrial. Meanwhile, 75-80% of hearing losses are au-
tosomal recessive, 10-20% autosomal dominant, 1-5% 
X-linked, and 2% mitochondrial (Figure 1).
Hearing loss can be classified by age at incidence, 
the location of defect in the ear, and associated physical 
symptoms. Based on age, hearing loss is divided into 
prelingual or congenital hearing loss and post-lingual 
or late hearing loss, according to the location of defect 
in ear, into conductive hearing loss (involvement of oti-
tis media or outer ear), sensorineural hearing loss (in-
Introduction
the prevalence of congenital hearing loss is about 1/1000 live births, over half of which occur due 
to genetic causes.1, 2 to date, over 30 different genetic 
loci have been reported to cause hearing loss, 70% of 
which cause non-syndromic hearing loss and the rest 
do syndromic hearing loss. Non-syndromic hearing loss 
is divided into four types, autosomal dominant DFNA, 
autosomal recessive DFNB, X-linked DFN, and mito-
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occur due to genetic causes. three mitochondrial mutations, a1555g in MtrNr1, a3243g in Mttl1, and a7445g in MttS1, are the most 
important non-syndromic sensorineural causes of hearing loss in some populations. The aim of this review was to study common mitochondrial 
mutations in people with hearing loss in iran.
EViDENCE aCQUiSitiON: Directory of Open Access Journals (DOAJ), Google Scholar, PubMed (NLM), LISTA (EBSCO) and Web of Sci-
ence were searched.
EVIDENCE SYNTHESIS: Studies have indicated that the mitochondrial mutations A3243G, A1555G, and A7445G play no significant part in 
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loss development in iran.
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Hearing loss after use of antibiotics (aminoglycosides) 
and due to diabetes, or sensorineural (non-syndromic) 
and neuromuscular disease-associated hearing loss are 
the most common types of this hearing loss.9, 10 Studies 
on deaf people of all ages in Finland and Japan demon-
strated that mitochondrial mutations were seen in 6.8% 
and 8.5% of people with non-syndromic sensorineural 
hearing loss, respectively.11, 12 it appears that the mito-
chondrial mutations occur in less than 1% of children 
with non-syndromic (prelingual) hearing loss.3 in Cau-
casian population, at least 5% of hearing loss has been 
demonstrated to develop after starting talking (post 
lingually) because of pathogenic mitochondrial muta-
tions.13 the mutations in the mitochondrial genome are 
likely to occur in around 20% of people with postlingual 
hereditary hearing loss; however, this figure can vary 
due to racial differences.14 Since 1988 and identification 
of the first case of hearing loss due to mutation in mito-
chondrial gene, over 70 point mutations, deletion, and 
DNA replication that are associated with a variety of 
genetic diseases in humans had been identified. Differ-
ent mutations in 12S rNa-coding MtrNr1 can cause 
non-syndromic hearing loss with maternal inheritance 
whose pattern can be similar to autosomal recessive for 
different reasons. the a1555g mutation that occurs in 
12S rRNA-coding MTRNR1 is the first mitochondrial 
mutation associated with non-syndromic hearing loss.15 
Several mutations in traNSer(UCN)-coding MttS1 
have been identified to be associated with sensorineural 
hearing loss, including t7511C, t7510C, a7445g, and 
7412insC.16 three mutations, i.e. t3271C, a3243g, 
and t4216C, have been detected in traNleu(UUr) 
(MTTL1), and A3243G was identified in 0.0314% of 
the population with hearing loss in Japan. Moreover, 
A3243G has been identified in people with diabetes 
mellitus.17
A1555G mutation
The study by Dachun et al. on the mitochondrial 
genes 12S rrNa and traNSer(UCN) culminated in 
the identification of the A1555G mutation in 12S rRNA 
which is an approximately homoplasmic mutation. 
This finding reflects that biochemical defects due to 
this mutation may become more likely with an increase 
in age, and this mutation is associated with different 
types of auditory anomalies.18 the a1555g mutation 
volvement of inner ear or auditory nerve), and mixed 
hearing loss (concurrent involvement of different parts 
of the ear), and according to physical symptoms, into 
syndromic hearing loss (accompanied by other physi-
cal symptoms) and non-syndromic hearing loss (with-
out other physical symptoms).3 in different populations, 
different mutations are considered to cause or be generi-
cally predisposing to hearing loss. For example, accord-
ing to the available evidence, GJB2 mutations account 
for 14.6% of non-syndromic hearing losses with reces-
sive inheritance pattern.4 Connexin 26 is the first ge-
netic locus known to cause non-syndromic hearing loss. 
the connexin 26 gene that localizes in this site codes 
the protein connexin 26. the mutation delg35 at con-
nexin 26 accounts for half of congenital hearing losses 
worldwide.5
Evidence synthesis
Mutations in mitochondrial genes
Approximately 25,000-35,000 nuclear genes and 37 
mitochondrial genes have been identified in humans. 
an estimate of about 1% of all human genes had been 
reported to cause hearing loss. in general, each mito-
chondria contains 3-10 mitochondrial chromosomes in 
its matrix, and each chromosome in human has 16569 
bp. Hearing loss is a heterogeneous disease from etio-
logical, clinical, and genetic perspectives.6, 7 12S rrNa 
and traNSer (UCN) are two mitochondrial genes that 
cause non-syndromic hearing loss. It is noteworthy that 
all types of hearing losses due to mutations in mito-
chondrial genes are inherited from the mother and affect 
both genes equally.8 There are different types of hearing 
loss that are due to mutation in the mitochondrial gene. 
Figure 1.—Frequency of different types of hearing loss.
Prelingual deaf children
1/1000
Syndromic 30% Non syndromic 70%
autosomal
recessive 80%
autosomal
dominant 15% X-linked 3% Mitochondrial 2%
genetic 50% Non genetic 50%
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those reported in other populations. However, because 
most of the studied cases of hearing loss were children 
of prelingual age, this frequency is similar to those in 
the populations at younger and prelingual age with 
hearing loss. The frequency of the A1555G mutation in 
population with post lingual hearing loss in Boushehr 
Province (south iran) was derived 4.35%,which is simi-
lar to those in the corresponding populations in Italy 
and England.13, 32 the a1555g mutation had a variable 
frequency among subpopulations of different ethnici-
ties in iran: azeri turkish (4.16%), lurs (0.0%), Fars 
(0.0%) and Bushehris (2.86%).33
A3243G mutation
the a3243g mutation in the trNaleu (UUr) gene 
represents one common cause of non-syndromic hear-
ing loss and diabetes.15 the age at incidence and inten-
sity of the hearing loss varied in the affected people. 
a number of cases are deaf at birth while some cases 
develop a slowly progressing hearing loss at puberty. 
in the trNaleu-coding Mttl1, three mutations, i.e. 
t3271C, a3243g, and t4216C, have been detected, 
of which the a3243g has been detected in people with 
diabetes mellitus. therefore, the a3253g mutation in 
people with diabetes mellitus should be taken into ac-
count because of hearing loss in these patients.16
in the provinces of Fars, Hormozgan, and Khouzestan, 
this mutation has not been found,31, 34, 35 but in Sistan va 
Balouchestan, its frequency was reported to be 0.9%.36
A7445G mutation
the a7445g is one of the known mutations reported 
to be associated with non-syndromic hearing loss.37-39 
the a7445g in the trNaSer (UCN)-coding MttS1 
was first detected in a Scottish family, and then in fami-
lies from New Zealand, Japan, France, Ukraine, Por-
tugal, and Hungary.16, 40 According to a study, the fre-
quency of this mutation was derived 0.33% in a number 
of Mongolian students.41
In a study in Iran, a mutation was reported to oc-
cur at the same gene locus but as a7445C with 1.61% 
frequency. This study demonstrated that the mitochon-
drial mutation a7445C is the cause of a small number 
of prelingual hearing losses, and the a7445g had no 
role in development of hearing loss in the population 
in MTRNR1 as well as the delG35 mutation in GJB2 
is potentially the most common hearing loss-associated 
mutation. Besides that, the A1555G is the most common 
mitochondrial mutation such that it has been reported to 
occur in 0.5-1% of the Caucasian population and com-
parably more frequently in Spaniards and Asian popula-
tions as well.19 Patients with the a1555g mutation are 
at increased risk of hearing loss after treatment with 
aminoglycoside. The carriers of this mutation are likely 
to develop hearing loss without undergoing pharmaco-
therapy.20, 21 the a1555g mutation was studied for the 
first time in a Korean population with non-syndromic 
hearing loss. In this study, 227 unrelated people were 
studied, two of whom were found to carry A1555G.22 a 
study reported that 2% of people with pelingual hearing 
loss carried the a1555g mutation.23 the incidence rate 
of the a1555g mutation is high in asian populations 
for example, 2.9% in China,24 3% in Japan,16 and 5.3% 
in indonesia.25 although the a1555g is a homoplasmic 
mutation, a number of families have been reported to 
carry this mutation as heteroplasmic.20, 26 the frequen-
cy of the A1555G has been reported to be about 1% in 
people with hereditary hearing loss in Tunisia,27 about 
1.8% in people with pelingual hereditary non-syndrom-
ic hearing loss in Turkey,28 and around 3.2% in people 
with non-syndromic hearing loss in Taiwan.29 the phe-
notypic incidence rate of the A1555G varies in a wide 
spectrum of the carriers ranging from those with normal 
hearing to those with absolute deafness.30 the variabil-
ity of the A1555G phenotype implies that other factors 
can be effective in the phenotypic incidence of mtDNA 
mutations, which affects the age at development and 
progression of hearing loss.
in a molecular investigation, the mitochondrial mu-
tations a7445g, a1555g, and a3243g in people with 
non-syndromic hearing loss in Fars province (Iran) were 
investigated, and none of the a1555g, a3243g and 
A7445G mutations were detected in this study. The evi-
dence indicated that the mitochondrial a1555g, a3243 
and A7445G mutations had no role in auditory deficits 
in the studied patients. It is recommended to study dif-
ferent mitochondrial mutations in a larger population in 
Fars province to further elucidate the role of the mito-
chondrial mutations in development of hearing loss in 
this province.31 A study reported the frequency of the 
A1555G in the population of Chaharmahal va Bakhtiari 
Province, southwest iran to be 0%, which is lower than 
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genes has been found to be more significant. Many mi-
tochondrial mutations have been found to be associated 
with prelingual and postlingual hearing loss. in certain 
populations such as ones from Spain and China, up to 
20% of postlingual hearing losses were found to be 
due to mitochondrial mutations.21 A study conducted in 
England demonstrated that the mitochondrial mutations 
were seen in around 30% of people with hearing loss 
with maternal inheritance.44 in the Far East populations, 
the frequency of the mitochondrial mutations is likely 
to be higher, especially 12S rRNA-coding MTRNA1 
and trNa genes that were found to be associated with 
hearing loss. Studies have indicated that the mitochon-
drial mutations A3243G, A1555G, and A7445G play no 
significant part in development of hearing loss in Iran 
(table i). Different variants of a7445C and g3316a 
have been identified in Iran. In the recent years, a large 
number of new mitochondrial mutations have been re-
ported to cause non-syndromic hearing loss.45 A study 
conducted in iran found a different mutation which was 
confirmed to be G3316A. According to the conducted 
studies, the change in g3316a associated with amino 
acid alanine conversion to treionin has been reported to 
occur in patients with diabetes mellitus, but its associa-
tion with hearing loss has not yet been confirmed and 
should be further investigated.36, 42
Conclusions
It is necessary to take into account the role of the 
mutations in the mitochondrial genes in hearing loss in 
the genetic counseling concerned with hearing loss in 
Iranian populations so that this role can be specified. 
Because of relatively high rate of consanguineous mar-
riage in most regions of iran, iranian populations can 
be considered a very rich source for studies on genetic 
diseases with autosomal recessive inheritance, includ-
ing hearing loss. Obviously, the findings of such stud-
ies can help screen for hearing loss in populations and 
consequently, appropriate genetic counseling as well 
as Preimplantation genetic diagnosis (PgD). Extensive 
studies on newborns can contribute greatly to determine 
the frequency of mitochondrial mutations more precise-
ly. Because of specific complexity of phenotypic inci-
dence, pattern of inheritance, and involvement of other 
factors in incidence and severity of the phenotypes in 
the mitochondrial mutations, special attention should be 
of Khouzestan Province, Iran. In this study, a different 
variant was found that was confirmed to be G3316A.35 
according to the conducted studies, the change in 
g3316a associated with amino acid alanine conver-
sion to treionin has been reported to occur in patients 
with diabetes mellitus.18, 42 A study was conducted to 
screen for three mitochondrial mutations a1555g, 
a3243g, and a3243g in people with hearing loss in 
Sistan va Balouchestan, Iran. In this study, people with 
autosomal recessive non-syndromic hearing loss were 
found to carry a different variant that was confirmed 
to be g3316a.36 Moreover, it seems that this variant 
is involved in LHON and hypertrophic cardiomyopa-
thy as well. However, its association with hearing loss 
remains to be confirmed and needs to be investigated 
further.18, 42, 43
Discussion
a number of principal and purposeful studies on non-
syndromic hearing with recessive inheritance have been 
conducted in iran. Most studies have been conducted 
on a specific locus, especially DFNB1 that contains the 
gene connexin-26. Surprisingly heterogeneous nature 
of hearing loss alongside Iran’s population diversity 
highlighted the necessity of conducting systematic pop-
ulation-based studies in this disorder so that purposeful 
structural studies are conducted according to the type of 
ethnicity and population. Therefore, study of different 
involved genes, especially the mitochondrial genes, in 
non-syndromic hearing loss with recessive inheritance 
as well as in people with acquired hearing loss with ge-
netic predisposition seems necessary to elucidate the 
etiology, potential pathogenic mechanisms, and subse-
quent treatment interactions. in general, in the conducted 
studies in different regions of the world, the association 
of three common mitochondrial mutations with hear-
ing loss has been investigated, consisting of a1555g 
in 12S rrNa-coding MtrNr1, three mutations, i.e. 
7472insC, a7445g, and t7511C, in Set(UCNtrNa)-
coding MttS1, and a3243g, t3271C, and t4216C in 
trNaleu (UUr)(Mttl1).16 Some of the mitochondrial 
genes including above mentioned ones play a part in 
hearing loss. However, their role in hearing loss with 
non-syndromic autosomal recessive pattern is less sig-
nificant, but in some populations such as ones form Chi-
na and Spain, the role of the mutations in mitochondrial 
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Table I.—Frequencies of mtDNA A1555G, A3243G and A7445G mutations in the previous studies in Iranian populations.
Title of study Types of hearing loss
Number of 
participants 
and location
Method Main results ref
mtDNa a1555g, a3243g and 
a7445g mutations
NSHl 72
Fars
PCr-rFlP None of the a1555g, a3243g and a7445g 
mutations were detected in this study. The evidence 
indicated that the mitochondrial a1555g, a3243 
and A7445G mutations had no role in auditory 
deficits in the studied patients.
(31)
Mitochondrial gene mutation 
screening
NSHl 110
Hormozgan
PCr-rFlP None of the 110 subjects were found to carry 
a1555g, a3243g and a7445g mutations. the 
association of A1555G، A3243G and A7445G 
mutations with hearing loss in Hormozgan province 
is negligible.
(34)
Common mitochondrial 
mutations in arab patients
arNSHl 62
Khuzestan
PCr-rFlP None of the investigated mutations, a1555g, 
a3243g and a7445g, were detected in this 
study. This study showed that mtDNA mutations 
consisting of g3316a and a7445C are responsible 
for arNSHl in a few number of cases in 
the studied sample and none of the a1555g, 
a3243g and a7445g mutations were found to be 
responsible for arNSHl in this population.
(35)
Frequency of the common 
mitochondrial DNa 
(mtDNa) mutations
NSHl 150
southwest 
subpopulations
PCr-rFlP None of these mutations were found in subjects with 
acquired and prelingual autosomal recessive NSHl 
from Chaharmahal va Bakhtiari province, but the 
A1555G mutation with frequency of 4.35% was 
found in postlingual NSHL patients in Boushehr 
province.
(32)
Screening of three common 
mtDNa mutations, a1555g, 
a3243g and a7445g
NSHl 110
Sistan va 
Baluchestan
PCr-rFlP None of the a1555g and a7445g mutations were 
detected in this study. However, found one sample 
to carry A3243G mutation (0.9%). This study 
showed that mtDNa mutations are responsible for 
less than 1% of pre-lingual arNSHl associated 
subjects.
(37)
Frequency of the mitochondrial 
a1555g mutation
NSHl 152 unrelated 
iranian 
populations
PCr-rFlP Totally, two patients carrying the homoplasmic 
A1555G mutation were identifid with a total 
frequency of 1.3% in Iran. The A1555G mutation 
had a variable frequency among subpopulations of 
different ethnicities in iran: azeri turkish (4.16%), 
Lurs (0.0%), Fars (0.0%) and Bushehris (2.86%).
(33)
Novel human mitochondrial 
trNaphe mutation in a patient 
with hearing impairment: a 
case study
NSHl A 7-year-old boy PCr- direct 
sequencing
Mitochondrial genes analysis revealed a novel 
heteroplasmic nucleotide substitution, m.628C. t, 
in the phenylalanine transfer RNA gene as a novel 
mitochondrial nucleotide change which may be 
important in mitochondrial deafness.
(46)
large-scale screening 
of mitochondrial DNa 
mutations among iranian 
patients with prelingual 
nonsyndromic hearing 
impairment
NSHi 1000 unrelated 
probands 
individuals in 
13 different 
provinces 
throughout iran.
PCr-rFlP Two of the studied mutations, namely A3243G and 
A7445G, were each found in a single family (a 
frequency of 0.1% for each). DNA sequencing led 
to the identification of G3316A substitution, with 
no prior link to Hi. screening for a3243g in the 
studied population identified 6 cases (0.6%) in 
probands and 10 (1%) in normal subjects. a1555g, 
the most common mtDNa mutation associated with 
deafness in other populations, was not found in the 
studied samples.
(47)
N\SHL: non-syndromic hearing loss; PCR-RFLP: PCR-restriction fragment length polymorphism; NSHI: nonsyndromic hearing impairment; ARNSHL: autosomal 
recessive non-syndromic hearing loss.
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18. Dai D, lu Y, Chen Z, Wei Q, Cao X, Xing g. Co-segregation of the 
t1095c with the a1555g mutation of the mitochondrial 12s rrna gene 
in a patient with non-syndromic hearing loss. Biochem Biophys Res 
Commun 2008;377:1152-5.
19. Sue C, Tanji K, Hadjigeorgiou G, Andreu A, Nishino I, Krishna S, et 
al. Maternally inherited hearing loss in a large kindred with a novel 
t7511c mutation in the mitochondrial DNa trnaser (ucn) gene. Neu-
rology 1999;52:1905-.
20. el-Schahawi M, lópez de Munain al, Sarrazin a, Shanske a, 
Basirico M, Shanske S, et al. two large spanish pedigrees with 
nonsyndromic sensorineural deafness and the mtdna mutation at 
nt 1555 in the 12s rrna gene evidence of heteroplasmy. Neurology 
1997;48:453-6.
21. Prezant TR, Agapian JV, Bohlman MC, Bu X, Öztas S, Qiu WQ, et 
al. Mitochondrial ribosomal rna mutation associated with both antibi-
otic–induced and non–syndromic deafness. Nat Genet 1993;4:289-94.
22. Bae JW, Lee KY, Choi SY, Lee SH, Park HJ, Kim UK. Molecular 
analysis of mitochondrial gene mutations in korean patients with non-
syndromic hearing loss. Int J Mol Med 2008;22:175-80.
23. Jacobs HT. Disorders of mitochondrial protein synthesis. Hum Mol 
Genet 2003;12:R293-R301.
24. li Z, li r, Chen J, liao Z, Zhu Y, Qian Y, et al. Mutational analy-
sis of the mitochondrial 12s rrna gene in chinese pediatric subjects 
with aminoglycoside-induced and non-syndromic hearing loss. Hum 
Genet 2005;117:9-15.
25. Malik SG, Pieter N, Sudoyo H, Kadir A, Marzuki S. Prevalence of 
the mitochondrial DNa a1555g mutation in sensorineural deafness 
patients in island southeast asia. J Hum genet 2003;48:480-3.
26. del Castillo F, Rodriguez-Ballesteros M, Martin Y, Arellano B, Gallo-
teran J, Morales-angulo C, et al. Heteroplasmy for the 1555a> g 
mutation in the mitochondrial 12s rrna gene in six spanish families 
with non-syndromic hearing loss. J Med Genet 2003;40:632-6.
27. Mkaouar-rebai E, tlili a, Masmoudi S, Charfeddine i, Fakhfakh F. 
New polymorphic mtdna restriction site in the 12s rrna gene detected 
in tunisian patients with non-syndromic hearing loss. Biochem Bio-
phys Res Commun 2008;369:849-52.
28. Tekin M, Duman T, Boğoçlu G, Incesulu A, Comak E, Fitoz S, et al. 
Frequency of mtdna a1555g and a7445g mutations among children 
with prelingual deafness in turkey. Eur J Pediatr 2003;162:154-8.
29. Wu CC, Chiu YH, Chen PJ, Hsu CJ. Prevalence and clinical features 
of the mitochondrial m. 1555a> g mutation in taiwanese patients with 
idiopathic sensorineural hearing loss and association of haplogroup f 
with low penetrance in three families. Ear Hearing 2007;28:332-42.
30. Ballana E, Morales E, Rabionet R, Montserrat B, Ventayol M, Bravo 
O, et al. Mitochondrial 12s rrna gene mutations affect rna secondary 
structure and lead to variable penetrance in hearing impairment. Bio-
chem Biophys Res Commun 2006;341:950-7.
31. Heydari S, Montazer Zohouri M, Farrokhi E, Shirmardi A, Banitalebi 
g, reisi S, et al. Molecular investigation of mtdna a1555g, a3243g 
and a7445g mutations among the non syndromic hearing loss cases 
in fars, iran. Feyz Journal of Kashan University of Medical Sciences 
2010;14.
32. Montazer-Zohour M, Hashemzadeh-Chaleshtori M, akbari Mt. 
Frequency of the common mitochondrial DNA (mtdna) mutations 
in non-syndromic hearing impairment in southwest subpopula-
tions of iran. Journal of Shahrekord University of Medical Sciences 
2012;14:81-91.
33. Zohour MM, Akbari M, Chaleshtori MH. Frequency of the mitochon-
drial a1555g mutation in iranian patients with non-syndromic hearing 
impairment. indian J Sci technol 2012;5:3378-83.
34. Asghari A, Montazer Zohori M, Farrokhi E, Banitalebi Dehkordi 
g, abolhasani M, azadeghan F, et al. Mitochondrial gene mutation 
screening in hearing loss patients, hormozgan, iran. Bimonthly Jour-
nal of Hormozgan University of Medical Sciences 2011;15:1-7.
35. Banitalebi G, Montazerzohor M, Farokhi E, Abolhasani M, Reissi S, 
Heydari S, et al. Study of three common mitochondrial mutations 
in arab patients with nonsyndromic hearing loss in khuzestan prov-
ince, ir iran. Journal of Shahrekord University of Medical Sciences 
2012;14:30-9.
paid to genetic counseling for families of people with 
hearing loss carrying the mitochondrial mutations. Ac-
cordingly, the mitochondrial mutations can cause hear-
ing loss. this argument should be investigated in popu-
lations with hearing loss. Based on the evidence, the 
mutations in the mtDNa and their role in development 
of hearing loss in populations are significant and fur-
ther studies on other ethnicities and with larger sample 
size are necessary to elucidate the role of these genes in 
hearing loss development in iran (table i).
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